The results showed that the salidroside could up-regulate TIMP-1 and reduce the expression of MMP-2, and the degree of lung tissue lesions, suggesting that the salidroside could inhibit the process of pulmonary fibrosis by regulating the balance of MMP-2/TIMP-1 [156]. Here, MMP2 is linked to pulmonary fibrosis.